Gen-Probe requests US approval of Procleix Ultrio for hepatitis B virus screening
This article was originally published in Clinica
Gen-Probe has applied to the US FDA for approval to use its Procleix Ultrio assay to screen donated blood for the hepatitis B virus (HBV). The San Diego, California company has submitted a supplemental biologics licence application (BLA) to use the assay to screen for HBV on both its semi-automated instrument platform and on the fully automated, high-throughput Tigris system. The FDA approved Procleix Ultrio to screen donated blood for HIV-1 and the hepatitis C virus (HCV) in late 2006. According to the World Health Organisation, more than 350 million people worldwide are chronically infected with HBV, with more than one million dying every year from the disease. Gen-Probe's blood screening products are marketed worldwide by Chiron, a subsidiary of pharma giant Novartis.
You may also be interested in...
Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies
Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.
FDA's Emergency Use Authorization for Malaria Drugs Could Hinder Trials of Other COVID-19 Treatments
Questions linger about the role the White House played in pushing the EUA, which comes with large product donations from Bayer and Sandoz that are expected to alleviate supply chain pressures for the drugs.
FDA Commissioner Stephen Hahn was added to the White House's pandemic task force as the outbreak grew, but he remained in a background role. That all changed the morning of 18 March, when President Trump tweeted: “I will be having a news conference today to discuss very important news from the FDA concerning the Chinese Virus!” A day later, Hahn was standing with Trump at the podium for the now-daily press briefings on Covid-19.